510(k) device
twiist Loop Algorithm
Deka Research and Development Corp. · Interoperable Automated Glycemic Controller (QJI, Class II) · First FDA decision Oct 15, 2026, newest Oct 15, 2026Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "twiist Loop Algorithm"
MAUDE reports
0
Brand "twiist Loop Algorithm", since 2015
PubMed studies
0
Mentioning "twiist Loop Algorithm"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing twiist Loop Algorithm
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- twiist Loop Algorithm510(k)
K262576 · Decided Oct 15, 2026 · 80 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "twiist Loop Algorithm", any status and sponsor, newest update first.
- Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 DiabetesNot yet recruiting
Mayo ClinicAcademic, hospital or other
NCT07808385 · 32 participants (planned) · Start Sep 2026 · Primary completion May 2027
Device: Automated Insulin Delivery (AID) · For: Type 1 Diabetes; Pregnancy
Sites: Stanford, California; Aurora, Colorado; Rochester, Minnesota · 4 sites in all
Deka Research and DevelopmentNot on our public-company list
NCT06853990 · 307 participants · Start Apr 14, 2025 · Primary completion Feb 25, 2026
Device: twiist insulin delivery system · For: Type 2 Diabetes; Insulin Treated Type 2 Diabetes Mellitus
Sites: La Jolla, California; Newport Beach, California; Santa Barbara, California · 30 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "twiist Loop Algorithm", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QJI
5,524 reports: 3,680 malfunction, 1,836 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "twiist Loop Algorithm"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QJI.
- SmartGuard TechnologyMedtronic MiniMed · 510(k) 2026
- SmartAdjust TechnologyInsulet Corporation · 510(k) 2024
- iLet Dosing Decision SoftwareBeta Bionics, Inc. · 510(k) 2026
- Control-IQ+ technologyTandem Diabetes Care, Inc. · 510(k) 2026
- Control-IQ TechnologyTandem Diabetes Care, Inc. · De Novo 2023
- iOS CamAPS FXCamDiab · 510(k) 2026
- Omnipod 6 algorithmInsulet Corporation · 510(k) 2026
- DBLG2Diabeloop · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.